Clincosm LogoSign in Get a demo

Myelodysplastic Syndromes

Showing NaN - NaN of 51
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

MDS Trial in Worldwide (Luspatercept)

Not yet recruiting
  • Myelodysplastic Syndromes
  • Los Alamitos, California
  • +53 more
Sep 13, 2023

MDS Trial in Worldwide (Luspatercept, Epoetin Alfa)

Not yet recruiting
  • Myelodysplastic Syndromes
  • Luspatercept
  • Epoetin Alfa
  • Concord, California
  • +100 more
Jul 20, 2023

MDS Trial in Worldwide (Tamibarotene + Azacitidine, Tamibarotene Matched Placebo + Azacitidine)

Recruiting
  • Myelodysplastic Syndromes
  • Tamibarotene + Azacitidine
  • Tamibarotene Matched Placebo + Azacitidine
  • Tucson, Arizona
  • +87 more
Feb 2, 2023

Acute Myeloid Leukemia, MDS, Chronic Myelomonocytic Leukemia Trial in Worldwide (JNJ-74856665, AZA, VEN)

Active, not recruiting
  • Acute Myeloid Leukemia
  • +2 more
  • Birmingham, Alabama
  • +22 more
Jan 27, 2023

Acute Myeloid Leukemia, Adult, MDS Trial in Marseille, Paris, Pierre-Bénite (ABD-3001)

Active, not recruiting
  • Acute Myeloid Leukemia, Adult
  • Myelodysplastic Syndromes
  • Marseille, France
  • +2 more
Jan 19, 2023

MDS, Acute Myeloid Leukemia Trial in France (BST-236)

Recruiting
  • Myelodysplastic Syndromes
  • Acute Myeloid Leukemia
  • Amiens, France
  • +16 more
Jan 2, 2023

MDS Trial in Worldwide (Magrolimab, Azacitidine, Placebo)

Active, not recruiting
  • Myelodysplastic Syndromes
  • Magrolimab
  • +2 more
  • Birmingham, Alabama
  • +168 more
Dec 7, 2022

Acute Leukemia in Remission, MDS, Myeloproliferative Syndrome Trial (Fecal Microbiota Transplantation)

Not yet recruiting
  • Acute Leukemia in Remission
  • +6 more
  • Fecal Microbiota Transplantation
  • Amiens, France
  • +19 more
Oct 18, 2022

MDS, Acute Myeloid Leukemia Trial in Australia, France, Germany (Imetelstat)

Not yet recruiting
  • Myelodysplastic Syndromes
  • Acute Myeloid Leukemia
  • Adelaide, Australia
  • +11 more
Oct 13, 2022

MDS, Leukemia, Myelomonocytic, Chronic, Leukemia, Myeloid, Acute Trial in Worldwide (Azacitidine, Pevonedistat)

Completed
Has Results
  • Myelodysplastic Syndromes
  • +2 more
  • Birmingham, Alabama
  • +58 more
Aug 24, 2022

MDS Trial in Worldwide (Oral Azacitidine, Durvalumab)

Active, not recruiting
Has Results
  • Myelodysplastic Syndromes
  • New Haven, Connecticut
  • +65 more
Aug 19, 2022

Leukemia, Myeloid, Acute, MDS Trial in Worldwide (Azacitidine, Durvalumab)

Active, not recruiting
Has Results
  • Leukemia, Myeloid, Acute
  • Myelodysplastic Syndromes
  • New Haven, Connecticut
  • +94 more
Jun 9, 2022

MDS, MDS Trial in France (Luspatercept Injection [Reblozyl], Eprex)

Recruiting
  • MDS
  • Myelodysplastic Syndromes
  • Luspatercept Injection [Reblozyl]
  • Eprex
  • Amiens, France
  • +30 more
May 19, 2022

MDS, Transfusion-dependent Anemia Trial in France (Transfusion)

Recruiting
  • Myelodysplastic Syndromes
  • Transfusion-dependent Anemia
  • Transfusion
  • Abbeville, France
  • +18 more
Apr 4, 2022

Leukemia, Myeloid, Acute, MDS, Leukemia, Myelomonocytic, Chronic Trial in Worldwide (H3B-8800 (RVT-2001))

Recruiting
  • Leukemia, Myeloid, Acute
  • +2 more
  • H3B-8800 (RVT-2001)
  • Stanford, California
  • +26 more
Mar 23, 2022

MDS, Thrombocytopenia Trial in Worldwide (Eltrombopag/Revolade, Placebo)

Active, not recruiting
  • Myelodysplastic Syndromes
  • Thrombocytopenia
  • Amiens, France
  • +63 more
Jan 13, 2022

MDS Trial in Worldwide (Luspatercept, Placebo)

Completed
Has Results
  • Myelodysplastic Syndromes
  • Stanford, California
  • +73 more
Nov 19, 2021

MDS Trial in France, Germany (N-Plate / romiplostim)

Completed
  • Myelodysplastic Syndromes
  • N-Plate / romiplostim
  • Annecy, France
  • +35 more
Sep 7, 2021

MDS, Leukemia, Myelomonocytic, Chronic Trial in Worldwide (Guadecitabine, Treatment Choice)

Completed
  • Myelodysplastic Syndromes
  • Leukemia, Myelomonocytic, Chronic
  • Duarte, California
  • +95 more
Sep 1, 2021

MDS Trial in France, Germany, United States (Oral rigosertib)

Completed
  • Myelodysplastic Syndromes
  • Oral rigosertib
  • Stanford, California
  • +13 more
Jun 15, 2021

Haploinsufficiency of RBM22 and SLU7 Genes in Del(5q)

Recruiting
  • Myelodysplastic Syndromes
  • +2 more
  • somatic cytogenetic and genetic characterization
  • Brest, France
  • +2 more
Jan 6, 2021

MDS Trial in France (EPREX)

Recruiting
  • Myelodysplastic Syndromes
  • Amiens, France
  • +38 more
Dec 1, 2020

Idiopathic Chronic Thrombocytopenia of Undetermined Significance

Recruiting
  • Thrombocytopenia
  • +2 more
  • blood sample
  • Bone marrow sample
  • Paris, France
  • +3 more
Oct 9, 2020

MDS Trial in France, Monaco (research of disease-related factors, research of comorbidities, physical performance)

Completed
  • Myelodysplastic Syndromes
  • research of disease-related factors
  • +2 more
  • Amiens, France
  • +30 more
Jul 29, 2020

MDS, Refractory Anemia With Excess Blasts, Chronic Myelomonocytic Leukemia Trial in Worldwide (rigosertib sodium)

Completed
  • Myelodysplastic Syndromes
  • +3 more
  • rigosertib sodium
  • Stanford, California
  • +34 more
Jun 29, 2020